Pegylated Interferon‐α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation
Clinical Infectious Diseases2010Vol. 50(5), pp. e30–e33
Citations Over TimeTop 10% of 2010 papers
Nassim Kamar, Lionel Rostaing, Florence Abravanel, Cyril Garrouste, Laure Esposito, Isabelle Cardeau‐Desangles, Jean‐Michel Mansuy, Janick Sèlves, Jean Marie Péron, Philippe Otal, Fabrice Muscari, Jacques Izopet
Abstract
This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.
Related Papers
- → Measuring PEG Retentions and EMCs of PEG Impregnated Softwood Specimens after Heat-treatment(2013)4 cited
- → Changes in the Amount of PEG Free-Flowing Back from PEG-Treated Waterlogged Archaeological Wood and the Compressive Strength According to Relative Humidity Conditions(2020)2 cited
- PEG(polyethylene glycol) 농도와 PEG / Gly(glycerol) 혼합비에 따른 견 피브로인 필름의 물성(2006)
- Effects of Polyethylene Glycol(PEG)-simulated Drought Stress on Mulberry Seed Germination and Physiology(2006)
- 대장내시경 전처치로서 4 L Polyethylene Glycol (PEG) 용액의 복용과 2 L PEG 용액 및 비사코딜 병합요법의 비교 분석(2008)